The BIOSECURE Act was passed with a large bipartisan majority in the House in 2024 and now awaits action in the Senate in 2025. Passage of the Act would be a significant first step in protecting ...

$510,000 of ACADIA PHARMACEUTICALS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Implementation of the Inflation ...

First introduced in January, the bipartisan BIOSECURE Act was voted through by the House Committee on Oversight and Accountability, a few weeks after the Senate Homeland Security and Governmental ...

Restore Protections for Dialysis Patients Act H.R. 7085, BIOSECURE Act S. 3558, to prohibit contracting with certain biotechnology providers, and for other purposes Implementation of P.L. 118-14 ...

The China-US trade war has spread to the biotech industry, as the US BIOSECURE Act looks to dampen Chinese influence on a range of services, including contract manufacturing. Ben Hargreaves ...

It is now apparent that nearly every Trump appointee is a diehard anti-China high priest or priestess. That’s not just Marco ...

The deal follows a $1.06 billion U.S. contract in July 2024 and a $1.24 billion agreement with an Asia-based pharma a few ...

Both deals came amid uncertainty over proposed federal legislation, known as the Biosecure Act, that could restrict WuXi AppTec's business dealings with U.S. companies. WuXi AppTec, however ...

Indian pharma companies like Dr Reddys, Zydus, Cipla, and Sun can sustain low double-digit EPS growth over the medium term.

Based on recent policy signals and statements from incoming administration officials, a picture of potential regulatory and policy changes that ...

Innophore will launch the CavitOmiX AI tool to screen for new drugs, predict side effects, and repurpose existing molecules.

Goodwin and KPMG brought together innovators, practitioners, regulators, and others for an annual symposium on the future of ...